References

1.
Alexander B, Vries A de, Goldstein R, Landwehr G. A Prothrombin Conversion Accelerator in Serum. Science 1949;109:545–5. doi:10.1126/science.109.2839.545.a.
2.
Alexander B, Goldstein R, Landwehr G, Addelson E. The prothrombin conversion accelerator of serum (SPCA): its partial purification and its properties compared with serum AC-globulin. Journal of Clinical Investigation 1950;29:881–95. doi:10.1172/jci102322.
3.
Koller F, Loeliger A, Duckert F. Experiments on a new Clotting Factor (Factor VII). Acta Haematologica 1951;6:1–18. doi:10.1159/000203899.
4.
Owren PA, Aas K. The Control of Dicumarol Therapy and the Quantitative Determination of Prothrombin and Proconvertin. Scandinavian Journal of Clinical and Laboratory Investigation 1951;3:201–8. doi:10.3109/00365515109060600.
5.
Banner DW, D’Arcy A, Chène C, Winkler FK, Guha A, Konigsberg WH, et al. The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor. Nature 1996;380:41–6. doi:10.1038/380041a0.
6.
Rao L, Rapaport S, Bajaj S. Activation of human factor VII in the initiation of tissue factor- dependent coagulation. Blood 1986;68:685–91. doi:10.1182/blood.v68.3.685.685.
7.
Furie B, Furie BC. The molecular basis of blood coagulation. Cell 1988;53:505–18. doi:10.1016/0092-8674(88)90567-3.
8.
McVey J, Boswell E, Mumford A, Kemball-Cook G, Tuddenham E. Factor VII deficiency and the FVII mutation database. Human Mutation 2000;17:3–17. doi:10.1002/1098-1004(2001)17:1<3::aid-humu2>3.0.co;2-v.
9.
OHara PJ, Grant FJ, Haldeman BA, Gray CL, Insley MY, Hagen FS, et al. Nucleotide sequence of the gene coding for human factor VII, a vitamin K-dependent protein participating in blood coagulation. Proceedings of the National Academy of Sciences 1987;84:5158–62. doi:10.1073/pnas.84.15.5158.
10.
Hagen FS, Gray CL, O’Hara P, Grant FJ, Saari GC, Woodbury RG, et al. Characterization of a cDNA coding for human factor VII. Proceedings of the National Academy of Sciences 1986;83:2412–6. doi:10.1073/pnas.83.8.2412.
11.
Giansily‐Blaizot M, Rallapalli PM, Perkins SJ, Kemball‐Cook G, Hampshire DJ, Gomez K, et al. The EAHAD blood coagulation factor VII variant database. Human Mutation 2020;41:1209–19. doi:10.1002/humu.24025.
12.
Herrmann FH, Wulff K, Auerswald G, Schulman S, Astermark J, Batorova A, et al. Factor VII deficiency: clinical manifestation of 717 subjects from Europe and Latin America with mutations in the factor 7 gene. Haemophilia 2009;15:267–80. doi:10.1111/j.1365-2516.2008.01910.x.
13.
Girolami A, Scarparo P, Bonamigo E, Treleani M, Lombardi AM. Homozygous FVII deficiencies with different reactivity towards tissue thromboplastins of different origin. Hematology 2012;17:350–4. doi:10.1179/1024533212z.000000000144.
14.
Peyvandi F, Palla R, Menegatti M, Mannucci P. Introduction: Rare Bleeding Disorders: General Aspects of Clinical Features, Diagnosis, and Management. Seminars in Thrombosis and Hemostasis 2009;35:349–55. doi:10.1055/s-0029-1225757.
15.
Borhany M, Pahore Z, Qadr Z ul, Rehan M, Naz A, Khan A, et al. Bleeding disorders in the tribe: Result of consanguineous in breeding. Orphanet Journal of Rare Diseases 2010;5. doi:10.1186/1750-1172-5-23.
16.
Mannucci PM, Duga S, Peyvandi F. Recessively inherited coagulation disorders. Blood 2004;104:1243–52. doi:10.1182/blood-2004-02-0595.
17.
World Federation of Hemophilia. Report on the Annual Global Survey 2021 2022.
18.
Mariani G, Herrmann F, Dolce A, Batorova A, Etro D, Peyvandi F, et al. Clinical phenotypes and factor VII genotype in congenital factor VII deficiency. Thrombosis and Haemostasis 2005;93:481–7. doi:10.1160/th04-10-0650.
19.
Dolce A, Mariani G, Di Minno MN. Bleeding symptoms at disease presentation and prediction of ensuing bleeding in inherited FVII deficiency. Thrombosis and Haemostasis 2013;109:1051–9. doi:10.1160/th12-10-0740.
20.
Girolami A, Bertozzi I, Rigoni I, Muzzolon R, Vettore S. Congenital FVII deficiency and thrombotic events after replacement therapy. Journal of Thrombosis and Thrombolysis 2011;32:362–7. doi:10.1007/s11239-011-0603-8.
21.
Girolami A, Marinis GB de, Vettore S, Girolami B. Congenital FVII Deficiency and Pulmonary Embolism: A Critical Appraisal of All Reported Cases. Clinical and Applied Thrombosis/Hemostasis 2012;19:55–9. doi:10.1177/1076029611436196.
22.
Giansily-Blaizot M, Marty S, Chen S-WW, Pellequer J-L, Schved J-F. Is the coexistence of thromboembolic events and Factor VII deficiency fortuitous? Thrombosis Research 2012;130:S47–9. doi:10.1016/j.thromres.2012.08.273.
23.
Peyvandi F, Palla R, Menegatti M, Siboni S, Halimeh S, Faeser B, et al. Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders. Journal of Thrombosis and Haemostasis 2012;10:615–21. doi:10.1111/j.1538-7836.2012.04653.x.
24.
Benlakhal F, Mura T, Schved JF, Giansily‐Blaizot M. A retrospective analysis of 157 surgical procedures performed without replacement therapy in 83 unrelated factor VII‐deficient patients. Journal of Thrombosis and Haemostasis 2011;9:1149–56. doi:10.1111/j.1538-7836.2011.04291.x.
25.
Quintavalle G, Riccardi F, Rivolta G, Martorana D, Di Perna C, Percesepe A, et al. F7 gene variants modulate protein levels in a large cohort of patients with factor VII deficiency: Results from a genotype-phenotype study. Thrombosis and Haemostasis 2017;117:1455–64. doi:10.1160/th17-02-0085.
26.
Kulkarni AA, Lee CA, Kadir RA. Pregnancy in women with congenital factor VII deficiency. Haemophilia 2006;12:413–6. doi:10.1111/j.1365-2516.2006.01287.x.
27.
Murray NP, Garcia C, Ilabaca J, Lagos N. Management of Pregnancy in a Chilean Patient with Congenital Deficiency of Factor VII and Glanzmann’s Thrombasthenia Variant. Case Reports in Obstetrics and Gynecology 2014;2014:1–4. doi:10.1155/2014/628386.
28.
Lee E‐J, Burey L, Abramovitz S, Desancho MT. Management of pregnancy in women with factor VII deficiency: A case series. Haemophilia 2020;26:652–6. doi:10.1111/hae.14086.